The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients.

Creative Commons License

Kaya A., Ciledag A., Gulbay B., Poyraz B., Çelik G., Sen E., ...Daha Fazla

Respiratory medicine, cilt.98, sa.7, ss.632-6, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 98 Sayı: 7
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1016/j.rmed.2003.12.017
  • Dergi Adı: Respiratory medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.632-6
  • Anahtar Kelimeler: angiogenesis, vascular endothelial growth factor (VEGF), non-small cell lung cancer (NSCLC), enzyme-linked immunosorbent assay (ELISA), FACTOR VEGF, EXPRESSION, SURVIVAL, CARCINOMA
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Angiogenesis, the formation of new blood vessels from the existing vascular bed, is essential step for the growth and invasion of the primary tumor. Vascular endothelial growth factor (VEGF) is known to play crucial rote in tumor angiogenesis. Increased serum VEGF levels may be associated with poor prognosis in patients with non-small cell lung cancer (NSCLC).